Trials / Completed
CompletedNCT00907101
Evaluate Effectiveness of Epiduo® Gel in Reducing Antibiotic Sensitive & Resistant Strains of Propionibacterium (P)Acnes
Evaluation of the Effectiveness of Epiduo® Gel (Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel) in Reducing Antibiotic Sensitive and Resistant Strains of P Acnes
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effectiveness of Epiduo® Gel in reducing antibiotic sensitive and resistant strains of P acnes in vivo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel (Epiduo® Gel) | Apply once daily |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2009-07-01
- Completion
- 2009-07-01
- First posted
- 2009-05-22
- Last updated
- 2022-08-01
- Results posted
- 2016-03-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00907101. Inclusion in this directory is not an endorsement.